XXI Wealth LLC’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.13M Sell
2,925
-17
-0.6% -$6.3K 0.52% 41
2026
Q1
$861K Sell
2,942
-445
-13% -$146K 0.49% 54
2025
Q4
$1.19M Buy
+3,387
New +$1.14M 0.72% 31

Other funds holding ELV

XXI Wealth LLC's ELV Position: Q2 2026 in Review

XXI Wealth LLC reduced its Elevance Health (ELV) stake by 0.58% in Q2 2026, selling an estimated $6.3K and leaving 2,925 shares worth $1.13M. The position accounts for 0.52% of the portfolio, ranked #41.

XXI Wealth LLC first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.19M in Q4 2025. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • XXI Wealth LLC held 2,925 shares of Elevance Health worth $1.13M as of Q2 2026.
  • XXI Wealth LLC sold 17 Elevance Health shares in Q2 2026, an estimated $6.3K.
  • Elevance Health made up 0.52% of XXI Wealth LLC's portfolio in Q2 2026, its #41 holding.
  • XXI Wealth LLC first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
  • XXI Wealth LLC's Elevance Health position peaked at $1.19M in Q4 2025.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on XXI Wealth LLC's 13F filing for Q2 2026, filed 14 Aug 2026.